Growth Metrics

Nephros (NEPH) Cash from Investing Activities (2016 - 2022)

Nephros has reported Cash from Investing Activities over the past 8 years, most recently at -$103000.0 for Q2 2022.

  • Quarterly results put Cash from Investing Activities at -$103000.0 for Q2 2022, changed N/A from a year ago — trailing twelve months through Sep 2024 was -$103000.0 (changed N/A YoY), and the annual figure for FY2024 was -$50000.0, up 33.33%.
  • Cash from Investing Activities for Q2 2022 was -$103000.0 at Nephros, down from -$34000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for NEPH hit a ceiling of -$13000.0 in Q3 2020 and a floor of -$137000.0 in Q1 2019.
  • Median Cash from Investing Activities over the past 4 years was -$34000.0 (2022), compared with a mean of -$55142.9.
  • Biggest five-year swings in Cash from Investing Activities: grew 7.14% in 2020 and later tumbled 376.92% in 2021.
  • Nephros' Cash from Investing Activities stood at -$14000.0 in 2019, then grew by 7.14% to -$13000.0 in 2020, then tumbled by 376.92% to -$62000.0 in 2021, then tumbled by 66.13% to -$103000.0 in 2022.
  • The last three reported values for Cash from Investing Activities were -$103000.0 (Q2 2022), -$34000.0 (Q1 2022), and -$62000.0 (Q3 2021) per Business Quant data.